drugset / Trial / NCT00004049

SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT00004049 ↗

Phase 1 Completed 36 enrolled Genzyme, a Sanofi Company
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of SR-45023A in treating patients who have locally advanced or metastatic solid tumors that have not responded to previous treatment.

Timeline

Start
1999-04
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject apomine Small molecule — Oral